Fujifilm Toyama Chemical’s Favipiravir Shows some Promise in Japanese and Chinese COVID-19 Clinical Trials TrialSite News, 18 Mar 2020 A drug called favipiravir, developed by a subsidiary of Fujifilm called Fujifilm Toyama Chemical, has generated encouraging…